Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Spirometer is a device used for measurement of lung capacity by measuring the amount of air that goes in and out of the lungs while breathing. In a spirometer test, the patient takes a deep breath into the spirometer tube which is attached to a reader for measurement and recording of air capacity of the lungs. Any deviation from the normal values of spirometer reading indicates malfunctioning of the lungs. Spirometer can be used for diagnosis of chronic pulmonary diseases such as cystic fibrosis, pulmonary fibrosis, emphysema, chronic bronchitis, asthma, bronchiectasis, and others. A spirometer can also aid in practicing breathing exercises in case of chronic pulmonary diseases and prevent accumulation of mucus and fluid inside the lungs. Additionally, a spirometer can also be used to assess lung function prior to a surgery such as bariatric surgery, knee replacement surgery, and others.
The global spirometer market is estimated to be valued at US$ 958.0 million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
Figure 1. Global Spirometer Market Share (%), By Region, 2021
The increasing prevalence of chronic respiratory disorders such as asthma, pulmonary fibrosis, emphysema, and others is expected to drive the growth of the global spirometer market over the forecast period.
For instance, according to asthma facts and statistics provided by the Asthma U.K. and British Lung Foundation Partnership, in 2017 around 5.4 million people in the U.K received treatment for asthma while three people die of asthma every day in the U.K. The same source states that around 77,124 people in the U.K. were admitted to hospital for asthma during 2017.
Moreover, according to the data provided by the Centers for Disease Control and Prevention in 2018, it has been observed that the prevalence of asthma in the U.S. has increased from 7.3% in 2001 to 7.9% in 2017.
Spirometer Market Report Coverage
||Market Size in 2021:
||US$ 958.0 Mn
|Historical Data for:
||2017 to 2020
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 1,808.3 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product Type: Hand Held, Table Top, Desktop
- By Technology Type: Volume Measurement, Flow Measurement, Peak Flow Measurement
- By Application: Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Pulmonary Fibrosis, Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User: Hospitals and Clinics, Home Healthcare
Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn
- Increasing prevalence of chronic respiratory disorders
- Technological advancement in healthcare sector
- Increasing products approval and launches
|Restraints & Challenges:
- Lack of awareness about symptoms of respiratory disorders in low income countries
- Irregularities in spirometer readings due to human error
Figure 2. Global Spirometer Market Value (US$ Mn), By Application, 2021
The increasing research and development activities for the development of technologically advanced spirometer is expected to drive the market growth over the forecast period.
For instance, in September 2019 a phase III clinical trial study was completed by the University of Illinois at Chicago in collaboration with Agency for Healthcare Research and Quality, an agency belonging to the U.S. Department of Health and Human Services. This clinical trial indicates that the use of spirometer can aid in identifying diagnostic error in patients suffering from chronic obstructive pulmonary disease and asthma.
The market players are focusing on product launches and regulatory approvals for their products which is expected to drive the market growth over the forecast period.
For instance, in June 2018, Henry Schein, Inc., a U.S. based distributor of healthcare products and services launched its new Henry Schein EasyOne Air spirometer which aids in accurate diagnosis of chronic obstructive pulmonary disease.
Global Spirometer Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 197,788,117 cases and 4,219,578 deaths due to Coronavirus (COVID-19) were reported till August 3, 2021, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. However, COVID-19 pandemic is expected to have a positive impact on spirometer market in this COVID-19 pandemic owing to need for methods which could be used to provide relief from breathing problems faced by COVID-19 patients.
For instance, according to a research article published by the American Journal of Emergency Medicine in January 2021, researchers at University of Illinois at Chicago have proposed the usage of incentive spirometry for treatment of COVID-19 patients suffering from mild to moderate respiratory symptoms by helping in expansion of lung capacity. Incentive spirometry is usually used in patients suffering from chronic obstructive pulmonary disease exacerbations, pneumonia, acute chest syndrome, and other similar respiratory disorders.
Global Spirometer Market - Restraint
The lack of awareness about symptoms of respiratory disorders in low income countries such as Africa, Bangladesh, Benin, and others, and irregularities in spirometer readings due to human error are the factors that are expected to hinder growth of the global spirometer market over the forecast period.
Major players operating in the global spirometer market include Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn